02.06.2013 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

191 Influence <strong>of</strong> Genetics on Paraoxonase 1 Activity in<br />

Monozygotic and Dizygotic Twins.<br />

L. Podolefsky 1 , K. M. Kelly 2 , J. C. Murray 3 , T. J. Raife 4 and G. Ludewig 1, 2 .<br />

1 Grad Program in Human <strong>Toxicology</strong>, University <strong>of</strong> Iowa, Iowa City, IA;<br />

2 Occupational and Environmental Health, University <strong>of</strong> Iowa, Iowa City, IA;<br />

3 Pediatrics, University <strong>of</strong> Iowa, Iowa City, IA; 4 Pathology, University <strong>of</strong> Iowa, Iowa<br />

City, IA.<br />

Paraoxonase 1 (PON1) is an important HDL-associated endogenous antioxidant<br />

found to play a major role in susceptibility to health effects from pesticides and oxidative<br />

stress. A number <strong>of</strong> gene polymorphisms influence both protein concentration<br />

and substrate specificity, as do certain lifestyle factors. However, reports about<br />

the influence <strong>of</strong> PON1 genetics have varied widely in the literature. <strong>The</strong> goal <strong>of</strong> this<br />

study was to examine the influence <strong>of</strong> genes and health data in a group <strong>of</strong> monozygotic<br />

and dizygotic twins to better understand the effect <strong>of</strong> genetics on PON1 activity<br />

levels. DNA, serum, and standard blood donation information was obtained<br />

from 6 sets <strong>of</strong> dizygotic twins and 13 sets <strong>of</strong> monozygotic twins. DNA was genotyped<br />

for polymorphisms within PON1, PON2, C-reactive protein (CRP), and<br />

tumor necrosis factor (TNF). PON1 activity was determined using phenyl acetate<br />

(PA) and CMPA [4-(Chloromethyl)phenyl acetate] as substrates, and genotyping<br />

was performed using the TaqMan-Applied Biosystems 7900 HT System. Using a<br />

general linear model, PON1 Q192R, L55M and C-108T were significantly associated<br />

with both PA and CMPA activity, with CMPA activity showing a stronger association<br />

with genetic variants. PON2 S311C was significantly associated with PA<br />

activity, but not CMPA. Activity for either substrate was not found to be associated<br />

with CRP or TNF polymorphisms. BMI was found to significantly correlate with<br />

CMPA activity, but not PA activity (correlation = -.34), while gender did not correlate<br />

with either substrate. Pair-wise analysis <strong>of</strong> all twins with identical PON genotypes<br />

showed no difference in PON activity variance between siblings, regardless <strong>of</strong><br />

zygosity. Though other shared or variant genetic and lifestyle factors may influence<br />

PON1 activity, the findings in this twin population suggest a strong link between<br />

PON activity and specific PON polymorphisms.<br />

192 Contribution <strong>of</strong> Environmental and Genetic Factors to<br />

Pancreatic Cancer.<br />

S. Chittiboyina, A. A. Bond, L. M. Kamendulis and B. A. Hocevar.<br />

Environmental Health, Indiana University School <strong>of</strong> Public Health, Bloomington, IN.<br />

Pancreatic cancer is the fourth leading cause <strong>of</strong> cancer deaths in the United States<br />

with a five year survival rate <strong>of</strong> less than 6%. Several environmental risk factors have<br />

been identified for pancreatic cancer, including dietary factors. In particular, high<br />

dietary intake <strong>of</strong> folate has been associated with a decreased incidence <strong>of</strong> pancreatic<br />

cancer, while low plasma folate levels are associated with an increased cancer risk. In<br />

conjunction with diet and lifestyle determinants, an individual’s folate pathway status<br />

is determined by their genetic makeup. In the present study, we determined the<br />

expression <strong>of</strong> selected SNPs in the folate metabolic pathway in a cohort <strong>of</strong> pancreatic<br />

cancer patients and healthy related and unrelated control groups. In agreement<br />

with other cancer studies, we show that cancer cases were more likely to express the<br />

TT allele <strong>of</strong> the methylene tetrahydr<strong>of</strong>olate reductase (MTHFR) C677T polymorphism<br />

compared to controls. Expression <strong>of</strong> this allele has been associated with low<br />

folate levels and elevated homocysteine (Hcy) levels. In support <strong>of</strong> this, we found<br />

that pancreatic cancer patients display elevated serum Hcy levels in comparison to<br />

both control groups. In addition, 48% <strong>of</strong> the pancreatic cancer patients exhibited<br />

hyperhomocysteinemia, as defined by a value >15 μM/L, (range 11.15 - 26.17<br />

μM/L), while no subjects in either control group exhibited hyperhomocysteinemia.<br />

In addition, we found that SNPs in betaine hydroxymethyltransferase (BHMT; rs<br />

3733890) and serine hydroxymethyl transferase (SHMT; rs 1979277) exhibited<br />

significantly different distributions between the case and control groups (p < 0.05).<br />

While a clear association was not seen between cancer risk and alcohol or smoking<br />

use in our population, self reported environmental exposure data suggested an association<br />

between pancreatic cancer and exposure to welding fumes. <strong>The</strong>se findings<br />

underlie the necessity to investigate further the interaction between environmental<br />

exposures and genetic factors which could provide further insight into the etiology<br />

<strong>of</strong> pancreatic cancer.<br />

193 <strong>The</strong> Impact <strong>of</strong> CYP2S1 Single Nucleotide Polymorphisms on<br />

the Metabolic Activation <strong>of</strong> the Anticancer Prodrug, AQ4N.<br />

N. Bajaj, N. M. Singh and A. M. Rowland. Chemistry and Biochemistry, NMSU,<br />

Las Cruces, NM.<br />

Cytochrome P450 2S1 (CYP2S1) is one <strong>of</strong> the most recent additions to the P450<br />

superfamily <strong>of</strong> enzymes. Although its physiological role has not yet been defined, it<br />

has been shown to influence metabolism <strong>of</strong> bioactive lipids, including<br />

40 SOT 2013 ANNUAL MEETING<br />

prostaglandins and retinoids. CYP2S1 is predominantly expressed in extra-hepatic<br />

epithelial cells. Its expression is elevated in cancer and catalyzes the metabolic activation<br />

<strong>of</strong> the anticancer prodrug, AQ4N, under hypoxic conditions. Interestingly<br />

our lab has also demonstrated that increased CYP2S1 expression may protect<br />

against AQ4 cytotoxicity under normoxic (21% O2) conditions. <strong>The</strong> main objective<br />

<strong>of</strong> this study is to determine whether individual variability in the CYP2S1 enzyme<br />

alters sensitivity <strong>of</strong> human lung cells to AQ4N and AQ4-mediated cytotoxicity.<br />

Five published CYP2S1 allelic variants have been published: CYP2S1*2<br />

(R380C), CYP2S1*3 (P466L), CYP2S1*4 (S61N), CYP2S1*5 (L230R).<br />

According to the NCBI database, two additional non-synonymous variants have<br />

been identified in cancer (A205T and L189F) and L189F is restricted to African<br />

American populations. We generate each <strong>of</strong> the polymorphisms in a CYP2S1-Flag<br />

mammalian expression vector, using site directed mutagenesis. Thus far, two stable<br />

lines (S61N and L189F) in bronchial epithelial cells (BEAS-2B) and four stable<br />

(S61N, R166H, A205T, and P466L) alveolar carcinoma cell lines (A549) have<br />

been made. Examination <strong>of</strong> AQ4N and AQ4 cytotoxicity in BEAS-2B cells revealed<br />

that both mutants (S61N and L189F) exhibit significantly increased cytotoxicity<br />

in response to AQ4N compared with wild type CYP2S1-Flag and<br />

pcDNA3.1 controls. Interestingly, the S61N polymorphism was significantly more<br />

sensitive to AQ4 than any <strong>of</strong> the other cell lines. This effect appears to be selective<br />

because cytotoxicity is not altered in response to a similar topoisomerase II inhibitor,<br />

mitoxantrone. We are currently testing the effects <strong>of</strong> these polymorphisms<br />

on AQ4N and AQ4 levels, using HPLC. Research funded by NIH NIGMS Grant<br />

# R25GM061222.<br />

194 <strong>The</strong> Remarkable Genotoxic Effect <strong>of</strong> Exposure to Ethyl<br />

Tertiary Butyl Ether in ALDH2 Knockout Mice.<br />

R. Wang, Z. Weng, K. Ohtani, M. Suda, Y. Yanagiba and T. Suzuki. Japan<br />

National Institute <strong>of</strong> Occupational Safety and Health, Kawasaki, Japan.<br />

Ethyl Tertiary Butyl Ether (ETBE) is used in gasoline for vehicles as a bi<strong>of</strong>uel.<br />

ETBE exposure induced liver damage and other health effects only at high concentrations<br />

in our previous studies, and its No Observed Adverse Effect Level<br />

(NOAEL) was calculated to be 500 ppm. However, in mice without ALDH2 enzyme<br />

activity, ETBE could induce DNA damage even at the NOAEL. To find out<br />

how low concentration at which ETBE shows its genotoxic effect, we did the exposure<br />

experiment with mice at low range <strong>of</strong> ETBE concentrations. METHODS:<br />

Male Aldh2-/- (KO), Aldh2+/- (HT) as well as C57BL/6 strain (WT), at 8 weeks<br />

old were exposed to ETBE at 0, 50, 200 and 500 ppm, 6 hr/day and 5 days/week,<br />

for 9 weeks. Blood, liver, epididymides were sampled 20 hr after the last exposure,<br />

and DNA damages were analyzed with comet assay in these tissues. RESULTS: <strong>The</strong><br />

tail intensity (TI) was used to evaluate the degree <strong>of</strong> DNA damage. In the leukocytes<br />

<strong>of</strong> WT mice, the TI value was not affected in any exposure group as compared<br />

to the control. However, the TI was significantly increased in 200 and 500 ppm<br />

groups <strong>of</strong> KO mice. Similar results were also obtained in HT mice, but there was<br />

no difference between the two types <strong>of</strong> mice. In liver cells and sperm, ETBE also induced<br />

DNA damage, but this effect was only observed in KO and HT mice as in<br />

the leukocytes. <strong>The</strong> NOAEL was 50 ppm in these types <strong>of</strong> mice. <strong>The</strong>se results suggest<br />

that ALDH2 deficiency may increase the susceptibility to the health effect <strong>of</strong><br />

ETBE exposure. We thank Ms. S. Watanabe for her assistance in the manipulation<br />

<strong>of</strong> the animals.<br />

195 MGMT Haplotypes Alter MGMT Expression and Can Thus<br />

Affect Response to Alkylating Agents.<br />

M. Xu, I. Nekhayeva, C. E. Cross, C. M. Rondelli and S. Z. Abdel-Rahman.<br />

OB/Gyn, UTMB, Galveston, TX.<br />

Glioblastoma (GB) is rapidly fatal. However, treatment with temozolomide (TMZ)<br />

and radiation is beneficial, but only for some patients. TMZ alkylates tumor DNA<br />

to form O6-alkylguanine (O6-AG) DNA adducts, inducing apoptosis. Because<br />

O6-AG is repaired by O6-methylguanine-DNA methyltransferase (MGMT), levels<br />

<strong>of</strong> MGMT are critical in determining tumor response to TMZ. Single nucleotide<br />

polymorphisms (SNPs) in the promoter/enhancer (P/E) region <strong>of</strong> the MGMT gene<br />

can alter its transcription and thus alter MGMT protein levels. Genetic variants are<br />

not arrayed as individual SNPs but as combinations forming specific “haplotypes”.<br />

To date, no studies have determined the haplotypes structure <strong>of</strong> the P/E region <strong>of</strong><br />

MGMT or their effect on its transcription. We sequenced 104 DNA samples from<br />

healthy individuals and identified 8 SNPS in this region (7/Y, 135/K, 290 /R,<br />

485/M, 575/M, 666/R, 777/M and 1099/Y). Using bioinformatics, we inferred<br />

the haplotypes encompassing these SNPs. We identified 21 potential haplotypes<br />

ranging in frequency from 0.39 to 0.00005, <strong>of</strong> which 10 were identified in our<br />

sample population as 20 paired haplotype combinations. We hypothesized that<br />

these haplotypes alter the regulation <strong>of</strong> MGMT transcription. Luciferase-reporter<br />

constructs containing different MGMT haplotypes were transfected into a GB cell

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!